Epidemiologic Profile of Patients With Valvular Heart Disease in Korea: A Nationwide Hospital-Based Registry Study
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
BACKGROUND: Valvular heart disease (VHD) is a common cause of cardiovascular morbidity and mortality worldwide; however, its epidemiological profile in Korea requires elucidation. METHODS: In this nationwide retrospective cohort study from the Korean valve survey, which collected clinical and echocardiographic data on VHD from 45 medical centers, we identified 4,089 patients with VHD between September and October 2019. RESULTS: The aortic valve was the most commonly affected valve (n = 1,956 [47.8%]), followed by the mitral valve (n = 1,598 [39.1%]) and tricuspid valve (n = 1,172 [28.6%]). There were 1,188 cases of aortic stenosis (AS) and 926 cases of aortic regurgitation. The most common etiology of AS was degenerative disease (78.9%). The proportion of AS increased with age and accounted for the largest proportion of VHD in patients aged 80–89 years. There were 1,384 cases of mitral regurgitation (MR) and 244 cases of mitral stenosis (MS). The most common etiologies for primary and secondary MR were degenerative disease (44.3%) and non-ischemic heart disease (63.0%), respectively, whereas rheumatic disease (74.6%) was the predominant cause of MS. There were 1,172 tricuspid regurgitation (TR) cases, of which 46.9% were isolated and 53.1% were associated with other valvular diseases, most commonly with MR. The most common type of TR was secondary (90.2%), while primary accounted for 6.1%. CONCLUSIONS: This report demonstrates the current epidemiological status of VHD in Korea. The results of this study can be used as fundamental data for developing Korean guidelines for VHD.
Abstract
BACKGROUND: Valvular heart disease (VHD) is a common cause of cardiovascular morbidity and mortality worldwide; however, its epidemiological profile in Korea requires elucidation. METHODS: In this nationwide retrospective cohort study from the Korean valve survey, which collected clinical and echocardiographic data on VHD from 45 medical centers, we identified 4,089 patients with VHD between September and October 2019. RESULTS: The aortic valve was the most commonly affected valve (n = 1,956 [47.8%]), followed by the mitral valve (n = 1,598 [39.1%]) and tricuspid valve (n = 1,172 [28.6%]). There were 1,188 cases of aortic stenosis (AS) and 926 cases of aortic regurgitation. The most common etiology of AS was degenerative disease (78.9%). The proportion of AS increased with age and accounted for the largest proportion of VHD in patients aged 80–89 years. There were 1,384 cases of mitral regurgitation (MR) and 244 cases of mitral stenosis (MS). The most common etiologies for primary and secondary MR were degenerative disease (44.3%) and non-ischemic heart disease (63.0%), respectively, whereas rheumatic disease (74.6%) was the predominant cause of MS. There were 1,172 tricuspid regurgitation (TR) cases, of which 46.9% were isolated and 53.1% were associated with other valvular diseases, most commonly with MR. The most common type of TR was secondary (90.2%), while primary accounted for 6.1%. CONCLUSIONS: This report demonstrates the current epidemiological status of VHD in Korea. The results of this study can be used as fundamental data for developing Korean guidelines for VHD.
참고문헌 (30)
- Coffey S, "Global epidemiology of valvular heart disease", Nat Rev Cardiol, 18, pp.853~864 (2021)
- Roth GA, "Global burden of cardiovascular diseases and risk factors, 1990-2019 : update from the GBD 2019 study", J Am Coll Cardiol, 76, pp.2982~3021 (2020)
- Maganti K, "Valvular heart disease : diagnosis and management", Mayo Clin Proc, 85, pp.483~500 (2010)
- Yadgir S, "Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990-2017", Circulation, 141, pp.1670~1680 (2020)
- Binder RK, "The year in cardiology : valvular heart disease", Eur Heart J, 41, pp.912~920 (2020)
- Baumgartner H, "Recommendations on the echocardiographic assessment of aortic valve stenosis : a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography", J Am Soc Echocardiogr, 30, pp.372~392 (2017)
- Lancellotti P, "Recommendations for the echocardiographic assessment of native valvular regurgitation : an executive summary from the European Association of Cardiovascular Imaging", Eur Heart J Cardiovasc Imaging, 14, pp.611~644 (2013)
- Jang SY, "Changes in the etiology of valvular heart disease in the rapidly aging Korean population", Int J Cardiol, 174, pp.355~359 (2014)
- Nkomo VT, "Burden of valvular heart diseases : a population-based study", Lancet, 368, pp.1005~1011 (2006)
- Iung B, "Epidemiology of valvular heart disease in the adult", Nat Rev Cardiol, 8, pp.162~172 (2011)
- Iung B, "Epidemiology of acquired valvular heart disease", Can J Cardiol, 30, pp.962~970 (2014)
- Iung B, "A prospective survey of patients with valvular heart disease in Europe : the Euro Heart Survey on Valvular Heart Disease", Eur Heart J, 24, pp.1231~1243 (2003)
- Ancona R, "Epidemiology of aortic valve stenosis (AS) and of aortic valve incompetence (AI): is the prevalence of AS", AI similar in different parts of the world?, 2020, pp.18(10), ~
- Yan AT, "Association between cardiovascular risk factors and aortic stenosis : the CANHEART aortic stenosis study", J Am Coll Cardiol, 69, pp.1523~1532 (2017)
- Andell P, "Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study", Heart, 103, pp.1696~1703 (2017)
- Nishimura RA, "2017 AHA", ACC focused update of the 2014 AHA, American Heart Association Task Force on Clinical Practice Guidelines, pp.J Am Coll Cardiol, 2017[DOI]
- Bursi F, "Heart failure and death after myocardial infarction in the community : the emerging role of mitral regurgitation", Circulation, 111, pp.295~301 (2005)
- Grayburn PA, "Functional mitral regurgitation : more questions than answers", JACC Cardiovasc Imaging, 14, pp.711~714 (2021)
- Eggebrecht H, "Transcatheter aortic valve implantation(TAVI)in Germany : more than 100, 000 procedures and now the standard of care for the elderly", EuroIntervention, 14, pp.e1549~e1552 (2019)
- Mack MJ, "3-Year outcomes of transcatheter mitral valve repair in patients with heart failure", J Am Coll Cardiol, 77, pp.1029~1040 (2021)
- Song C, "Age-related outcomes after transcatheter mitral valve repair in patients with heart failure : analysis from COAPT", JACC Cardiovasc Interv, 15, pp.397~407 (2022)
- Zühlke L, "Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease : the Global Rheumatic Heart Disease Registry(the REMEDY study)", Eur Heart J, 36, pp.1115~ (2015)[DOI]
- Watkins DA, "Global, regional, and national burden of rheumatic heart disease, 1990-2015", N Engl J Med, 377, pp.713~722 (2017)
- Negi PC, "Gender differences in the epidemiology of Rheumatic Fever", Rheumatic heart disease(RF, Indian Heart J, pp.2020, 72[DOI]
- Rubtsova K, "Sexual dimorphism in autoimmunity", J Clin Invest, 125, pp.2187~2193 (2015)
- Dietz MF, "Sex-specific differences in etiology and prognosis in patients with significant tricuspid regurgitation", Am J Cardiol, 147, pp.109~115 (2021)
- Summerhill VI, "Sex-specific features of calcific aortic valve disease", Int J Mol Sci, 21, pp.5620~ (2020)
- Nitsche C, "Gender-specific differences in valvular heart disease", Wien Klin Wochenschr, 132, pp.61~68 (2020)
- Lüscher TF, "Valvular heart disease : tricuspid regurgitation is the new frontier", Eur Heart J, 39, pp.3555~3557 (2018)
- Prihadi EA, "Morphologic types of tricuspid regurgitation : characteristics and prognostic implications", JACC Cardiovasc Imaging, 12, pp.491~499 (2019)